|3.61||-0.07 / -1.90%|
Data as of Jan 23
|3.74||+0.13 / +3.60%|
The 2 analysts offering 12-month price forecasts for Female Health Co have a median target of 7.25, with a high estimate of 7.50 and a low estimate of 7.00. The median estimate represents a +100.83% increase from the last price of 3.61.
The current consensus among 2 polled investment analysts is to Buy stock in Female Health Co. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.